Back to search
FDAFDA · Food and drugs·Recall number D-0630-2020

Levetiracetam Oral Solution 100mg/mL, 473 mL (16 fl. oz.) Bottles, Rx Only, Distributed by: Lannett Company, Inc. Philadelphia, PA 19136, NDC 54838-0548-80

Published December 25, 2019 · Recall initiated: December 6, 2019

Summary

FDA records drug Class I recall D-0630-2020, published December 25, 2019 and initiated December 6, 2019. Recalling firm: Lannett Company, Inc.; Status: Terminated; Reported quantity: 16,668 bottles; Lot: Lot #: 2190A, 2191A, Exp. Date 07/2021. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbial Contamination of Non-sterile Products: Out-of-specification results obtained for Total Aerobic Microbial Count.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Lannett Company, Inc.
Distributor
Nationwide within the United States
Lot
Lot #: 2190A, 2191A, Exp. Date 07/2021
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Levetiracetam Oral Solution 100mg/mL, 473 mL (16 fl. oz.) Bottles, Rx Only, Distributed by: Lannett Company, Inc. Philadelphia, PA 19136, NDC 54838-0548-80 recalled?

Yes. FDA published recall D-0630-2020 on December 25, 2019. Reported hazard: Microbial Contamination of Non-sterile Products: Out-of-specification results obtained for Total Aerobic Microbial Count.

What should I do if I have this product?

Voluntary: Firm initiated · Letter